BioSpace News Archive

CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes. A focus on removing long-list products, and the increased use of generics has seen capital re-directed into R&D – with Takeda-Shire now possessing the world’s second largest pipeline of drug targets (211).

Visitors to Demo Widex ENERGY CELL™ Technology and Get a Live Hearing Demo of Second Generation Widex EVOKE™

Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new class of cellular medicines, today announced the appointment of Natalie Holles, president and chief operating officer of Audentes Therapeutics, as a member of the company’s board of directors and Greg Whitehead as senior vice president and chief quality officer

Micronic released the new innovative 2.00ml Tubes with External thread. These 2.00ml tubes are the first tubes of its kind, enabling researchers to store high volume samples in a space-efficient 96-well format

Sydys Corporation announced that on March 25, 2019, the Company voluntarily filed a Form 15 with the United States Securities and Exchange Commission to voluntarily deregister its common stock and suspend its reporting obligations under the Securities Exchange Act of 1934, as amended.

New England Journal of Medicine Study Reports Harmful Side Effects of Daily Aspirin

CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, will be presenting three abstracts at the 2019 American Association for Cancer Research (AACR) Annual Meeting, March 29 - April 3, 2019, at the Georgia World Congress Center in Atlanta.

Riverside Partners, a Boston-based private equity firm, is introducing Revecore, a company bringing together best-in-class organizations to deliver specialized services in the most challenging areas of hospital revenue cycle management.

MediSpend and Henry Schein will co-host an online webinar, “Effective Analytics Using Organizational Data,” about using compliance related data to provide enterprise-wide business value and building a compliance data model to meet an organization’s unique analytic, monitoring and auditing needs

Acutus Medical today announced the publication of “High Resolution Non-Contact Charge Density Mapping of Endocardial Activation” in JCI Insight.